SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-110225
Filing Date
2021-04-08
Accepted
2021-04-08 16:09:56
Documents
18
Period of Report
2021-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d155184d8k.htm   iXBRL 8-K 29510
2 EX-1.1 d155184dex11.htm EX-1.1 197394
3 EX-5.1 d155184dex51.htm EX-5.1 13658
4 EX-99.1 d155184dex991.htm EX-99.1 9888
8 GRAPHIC g155184g0408110636843.jpg GRAPHIC 1785
9 GRAPHIC g155184g0408110907661.jpg GRAPHIC 3393
10 GRAPHIC g155184sp47.jpg GRAPHIC 10481
  Complete submission text file 0001193125-21-110225.txt   458083

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210407.xsd EX-101.SCH 3093
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210407_lab.xml EX-101.LAB 18887
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210407_pre.xml EX-101.PRE 11875
11 EXTRACTED XBRL INSTANCE DOCUMENT d155184d8k_htm.xml XML 3487
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 21815031
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences